Article Sidebar

Submitted
November 29, 2021
Accepted
August 12, 2023
Published
September 29, 2025
Download
PDF
Statistic
Read Counter : 105 Download : 111

Downloads

Download data is not yet available.

Main Article Content

Abstract

In Indonesia, life expectancy has risen significantly. The rise in life expectancy is, of course, directly proportional to the rise in the elderly population (elderly). Coronary heart disease, hypertension, metabolic disorders, and arthritis are all problems that the elderly face on a daily basis. To improve the quality of life of the elderly, preventive efforts that are tailored to their physiological needs are required. However, descriptive data on the parameters to be examined in this group are required before conducting an intervention. The authors are encouraged to know the description of total cholesterol levels in the elderly who are in the DPC Muhammadiyah Pondok Aren environment based on the background of the problems described above. Glucose, hemoglobin, and total cholesterol levels in plasma will be measured. This study collects primary data from respondents by taking finger blood samples, which are then measured using the Easy Touch® tool. Total sampling was used, and the number of samples that met the inclusion criteria was 13 people. The data is analyzed to generate distributions and percentages. The findings revealed that 85.19 percent of the elderly had normal blood glucose levels. According to age, the elderly aged 60-74 years have 83.33 percent normal blood glucose levels, while the elderly aged 75-70 years have 86.67 percent normal blood glucose levels. According to gender, elderly men with normal blood glucose levels account for approximately 84.21 percent of the population, while elderly women with normal blood glucose levels account for approximately 87.50 percent. It was determined that over half of the elderly in PSTW

Keywords

Fahr Disease CT Scan Basal Ganglia

Article Details

License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Abdulmannan, A. F., Prodjokusumo, H. M., Rahman, P. W., Fitriana, R., & Kurnia, A. (2025). Fahr Disease : A Case Repor. Sanus Medical Journal, 7(1), 88–101. https://doi.org/10.22236/sanus.v7i1.7955
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Al Ali, J., Yang, J., Phillips, M. S., Fink, J., Mastrianni, J., & Seibert, K. (2023a). A case report of a patient with primary familial brain calcification with a PDGFRB genetic variant. Frontiers in Neurology, 14, 1235909. https://doi.org/10.3389/fneur.2023.1235909
  2. Al Ali, J., Yang, J., Phillips, M. S., Fink, J., Mastrianni, J., & Seibert, K. (2023b). A Novel Mutation in PDGFRB in a Patient with Primary Familial Brain Calcification: Case Report (P2-12.005). Neurology, 100(17_supplement_2), 1584. https://doi.org/10.1212/WNL.0000000000202000
  3. Balck, A., Schaake, S., Kuhnke, N. S., Domingo, A., Madoev, H., Margolesky, J., … Westenberger, A. (2021). Genotype-Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene Review. Movement Disorders: Official Journal of the Movement Disorder Society, 36(11), 2468–2480. https://doi.org/10.1002/mds.28753
  4. Bonato, G., Cimino, P., Pistonesi, F., Salviati, L., Bertolin, C., & Carecchio, M. (2024). Non-Motor Symptoms in Primary Familial Brain Calcification. Journal of Clinical Medicine, 13(13), 3873. https://doi.org/10.3390/jcm13133873
  5. Carecchio, M., Mainardi, M., & Bonato, G. (2023). The clinical and genetic spectrum of primary familial brain calcification. Journal of Neurology, 270(6), 3270–3277. https://doi.org/10.1007/s00415-023-11650-0
  6. Cen, Z., Chen, Y., Chen, S., Wang, H., Yang, D., Zhang, H., … Luo, W. (2020). Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification. Brain: A Journal of Neurology, 143(2), 491–502. https://doi.org/10.1093/brain/awz392
  7. Chelban, V., Carecchio, M., Rea, G., Bowirrat, A., Kirmani, S., Magistrelli, L., … Houlden, H. (2020). MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism. Neurology. Genetics, 6(2), e399. https://doi.org/10.1212/NXG.0000000000000399
  8. Chen, S.-Y., Ho, C.-J., Lu, Y.-T., Lin, C.-H., Lan, M.-Y., & Tsai, M.-H. (2023). The Genetics of Primary Familial Brain Calcification: A Literature Review. International Journal of Molecular Sciences, 24(13), 10886. https://doi.org/10.3390/ijms241310886
  9. Donzuso, G., Mostile, G., Nicoletti, A., & Zappia, M. (2019). Basal ganglia calcifications (Fahr’s syndrome): Related conditions and clinical features. Neurological Sciences, 40(11), 2251–2263. https://doi.org/10.1007/s10072-019-03998-x
  10. Grangeon, L., Wallon, D., Charbonnier, C., Quenez, O., Richard, A.-C., Rousseau, S., … Nicolas, G. (2019). Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype. Brain: A Journal of Neurology, 142(6), 1573–1586. https://doi.org/10.1093/brain/awz095
  11. Hebestreit, S., Schwahn, J., Sandikci, V., Maros, M. E., Valkadinov, I., Yilmaz, R., … Weishaupt, J. H. (2023). PSEN1/SLC20A2 double mutation causes early-onset Alzheimer’s disease and primary familial brain calcification co-morbidity. Neurogenetics, 24(3), 209–213. https://doi.org/10.1007/s10048-023-00723-x
  12. Keogh, M. J., Pyle, A., Daud, D., Griffin, H., Douroudis, K., Eglon, G., … Chinnery, P. F. (2015). Clinical heterogeneity of primary familial brain calcification due to a novel mutation in PDGFB. Neurology, 84(17), 1818–1820. https://doi.org/10.1212/WNL.0000000000001517
  13. Khojasteh, M., Soleimani, P., Ghasemi, A., Taghizadeh, P., Rohani, M., & Alavi, A. (2024). JAM2 variants can be more common in primary familial brain calcification (PFBC) cases than those appear; may be due to a founder mutation. Neurological Sciences, 45(8), 3829–3844. https://doi.org/10.1007/s10072-024-07419-6
  14. Magalhães, M., Alves, M., Paulino Ferreira, L., Alves, J., & Durães, D. (2024). Basal Ganglia Calcification: A Case Report of Two Siblings With Fahr’s Disease. Cureus, 16(2), e53434. https://doi.org/10.7759/cureus.53434
  15. Mathijssen, G., van Valen, E., de Jong, P. A., Golüke, N. M. S., van Maren, E. A., Snijders, B. M. G., … Koek, H. L. (2024). The Association between Intracranial Calcifications and Symptoms in Patients with Primary Familial Brain Calcification. Journal of Clinical Medicine, 13(3), 828. https://doi.org/10.3390/jcm13030828
  16. Nicolas, G., Charbonnier, C., Campion, D., & Veltman, J. A. (2018). Estimation of minimal disease prevalence from population genomic data: Application to primary familial brain calcification. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics, 177(1), 68–74. https://doi.org/10.1002/ajmg.b.32605
  17. Peters, M. E. M., de Brouwer, E. J. M., Bartstra, J. W., Mali, W. P. T. M., Koek, H. L., Rozemuller, A. J. M., … de Jong, P. A. (2020). Mechanisms of calcification in Fahr disease and exposure of potential therapeutic targets. Neurology. Clinical Practice, 10(5), 449–457. https://doi.org/10.1212/CPJ.0000000000000782
  18. Sennfält, S., Gustavsson, P., Malmgren, H., Gilland, E., Almqvist, H., Oscarson, M., … Paucar, M. (2024). Novel findings in a Swedish primary familial brain calcification cohort. Journal of the Neurological Sciences, 460, 123020. https://doi.org/10.1016/j.jns.2024.123020
  19. Shen, Y., Shu, S., Ren, Y., Xia, W., Chen, J., Dong, L., … Zhang, X. (2021). Case Report: Two Novel Frameshift Mutations in SLC20A2 and One Novel Splice Donor Mutation in PDGFB Associated With Primary Familial Brain Calcification. Frontiers in Genetics, 12. https://doi.org/10.3389/fgene.2021.643452
  20. Srichawla, B. S., Andrade, E., & Kipkorir, V. (2023). Decoding brain calcifications: A single-center descriptive case series and examination of pathophysiological mechanisms. SAGE Open Medical Case Reports, 11, 2050313X231197521. https://doi.org/10.1177/2050313X231197521
  21. Tadic, V., Westenberger, A., Domingo, A., Alvarez-Fischer, D., Klein, C., & Kasten, M. (2015). Primary familial brain calcification with known gene mutations: A systematic review and challenges of phenotypic characterization. JAMA Neurology, 72(4), 460–467. https://doi.org/10.1001/jamaneurol.2014.3889
  22. Taglia, I., Kuipers, D. J. S., Breedveld, G. J., Mignarri, A., Dotti, M. T., Federico, A., & Bonifati, V. (2019). Primary familial brain calcification caused by MYORG mutations in an Italian family. Parkinsonism & Related Disorders, 67, 24–26. https://doi.org/10.1016/j.parkreldis.2019.09.021
  23. Thillaigovindan, R., Arumugam, E., Rai, R., R, P., & Kesavan, R. (2019). Idiopathic Basal Ganglia Calcification: Fahr’s Syndrome, a Rare Disorder. Cureus, 11(10), e5895. https://doi.org/10.7759/cureus.5895
  24. Wazir, M. H., Ali, Y., Mufti, A. Z., Ahmad, A., & Ahmad, H. (2023). Fahr’s Syndrome: A Rare Case Presentation. Cureus, 15(10), e47812. https://doi.org/10.7759/cureus.47812
  25. Xu, X., Sun, H., Luo, J., Cheng, X., Lv, W., Luo, W., … Liu, J.-Y. (2023). The Pathology of Primary Familial Brain Calcification: Implications for Treatment. Neuroscience Bulletin, 39(4), 659–674. https://doi.org/10.1007/s12264-022-00980-0
  26. Yang, Q., Li, J., Jiao, B., & Weng, L. (2022). Primary familial brain calcification in a patient with a novel compound heterozygous mutation in MYORG presenting with an acute ischemic stroke: A case report. Annals of Translational Medicine, 10(7), 423. https://doi.org/10.21037/atm-21-4883
  27. Yektay Farahmand, M., Wasselius, J., Englund, E., Braverman, I., Puschmann, A., & Ilinca, A. (2024). Small vessel disease in primary familial brain calcification with novel truncating PDGFB variants. Neurologia I Neurochirurgia Polska, 58(1), 94–105. https://doi.org/10.5603/pjnns.97716
  28. Zhang, M., Jia, Y., Wang, H., Liu, A., Gao, L., & Wang, Y. (2024). Epileptic seizure as the prominent symptom in Fahr syndrome, case report and literature review. Seizure, 123, 88–91. https://doi.org/10.1016/j.seizure.2024.09.023
  29. Zhao, M., Su, H.-Z., Zeng, Y.-H., Sun, Y., Guo, X.-X., Li, Y.-L., … Chen, W.-J. (2022). Loss of function of CMPK2 causes mitochondria deficiency and brain calcification. Cell Discovery, 8(1), 128. https://doi.org/10.1038/s41421-022-00475-2
  30. Zhao, T., Xu, S., Liu, S., Xu, J., Zhang, X., & Zhan, Y. (2023). Fahr’s disease linked to a novel mutation in MYORG variants manifesting as paroxysmal limb stiffness and dysarthria: Case report and literature review. Molecular Genetics & Genomic Medicine, 11(12), e2276. https://doi.org/10.1002/mgg3.2276